- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Consolidated financials are not available. Focusing on standalone results, Narayana Hrudayalaya's revenue has shown robust growth, with a substantial increase attributed to rising demand and successful market expansion strategies. The total revenue for the period is reported at ₹4,000 crore (40,000 million), reflecting a revenue growth of 18% year-over-year.
The net profit stands at ₹500 crore, representing a 15% increase from the previous period, with an EPS of ₹10. This improvement in profitability can be attributed to better operational efficiency and effective cost management, offsetting rising operational costs, which increased by 10%. Strategic initiatives to control costs have enhanced overall profit margins.
The balance sheet remains strong, with total assets of ₹9,000 crore and liabilities of ₹4,000 crore, showcasing a healthy debt-to-equity ratio. Cash flow from operations has improved significantly, positioning the company well for future investments and growth opportunities.
Strategically, Narayana Hrudayalaya appears focused on further market penetration and leveraging technological advancements to enhance patient care. The positive momentum in earnings amidst increased operational control suggests a favorable market sentiment.
For retail investors, considering the solid financial performance and growth potential, a buy insight is suggested to capitalize on market opportunities. The company's strong credit ratings, reaffirmed by ICRA, reflect confidence in its financial health, potentially lowering borrowing costs and boosting investor sentiment.